ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
A136
|
49 |
34K |
9 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
49
|
34K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
A136
|
49 |
34K |
1 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
49
|
34K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
What have we got?
|
|
A136
|
49 |
34K |
8 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
49
|
34K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: AIPAC-003 safety lead-in data presented at ESMO Breast 2024
|
|
A136
|
16 |
7.9K |
21 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
16
|
7.9K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
The elephant in the room
|
|
A136
|
8 |
5.8K |
0 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
8
|
5.8K
|
0
|
|
ASX - By Stock
|
IMM |
The elephant in the room
|
|
A136
|
8 |
5.8K |
0 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
8
|
5.8K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
A136
|
56 |
31K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
56
|
31K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: First Clinical Data announced from 90mg Dosing of Efti
|
|
A136
|
56 |
31K |
21 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
56
|
31K
|
21
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
A136
|
2.7K |
1.1M |
16 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
A136
|
2.7K |
1.1M |
14 |
04/11/23 |
04/11/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
A136
|
2.7K |
1.1M |
4 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
AVL |
Re:
Vanadium news
|
|
A136
|
6.5K |
2.9M |
0 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
6.5K
|
2.9M
|
0
|
|
ASX - By Stock
|
AVL |
Re:
Vanadium news
|
|
A136
|
6.5K |
2.9M |
0 |
25/07/23 |
25/07/23 |
ASX - By Stock
|
6.5K
|
2.9M
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
A136
|
2.7K |
1.1M |
2 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
AVL |
Re:
Vanadium news
|
|
A136
|
6.5K |
2.9M |
4 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
6.5K
|
2.9M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
A136
|
8 |
3.7K |
0 |
13/06/23 |
13/06/23 |
ASX - By Stock
|
8
|
3.7K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
A136
|
743 |
340K |
4 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
743
|
340K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive final data in 2nd line head and neck cancer at ASCO
|
|
A136
|
26 |
11K |
1 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
26
|
11K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive final data in 2nd line head and neck cancer at ASCO
|
|
A136
|
26 |
11K |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
26
|
11K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive final data in 2nd line head and neck cancer at ASCO
|
|
A136
|
26 |
11K |
6 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
26
|
11K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
A136
|
743 |
340K |
4 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
743
|
340K
|
4
|
|